EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Management of Neonatal Hyperglycaemia in Sweden—A Survey Study

Ludvig Henriksson Frithiof iD, Magnus Domellöf, Itay Nilsson Zamir iD

Acta Paediatrica · 2025

DOI: 10.1111/apa.17583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Ludvig Henriksson Frithiof und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Hyperglycemia, Infant, Premature, Diseases, Practice Patterns, Physicians'. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Region Västerbotten, Umeå Universitet, Svenska Läkaresällskapet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Neonatal hyperglycaemia is associated with a multitude of adverse outcomes, including mortality and impaired neurological development. The aim of this study was to characterise the current management of neonatal hyperglycaemia in Swedish neonatal units.

Methods

A digital survey was sent to 27 Swedish neonatal units providing care to preterm infants born before 32 completed gestational weeks.

Results

Sixty‐eight responses were collected from 21 different units. Thirty‐two percent (22/68) of clinicians reported having a local treatment guideline for neonatal hyperglycaemia. Hyperglycaemia was defined as a glucose concentration above a value in the range of 8.0–10.0 mmol/L by 62.5% of clinicians, while 16.7% and 21.8% used a definition between 10.1 and 12.0 mmol/L and > 12 mmol/L, respectively. Intravenous glucose reduction was initiated at higher glucose concentrations by clinicians working at university hospital units ( p = 0.006). Glucose concentration threshold for initiation of insulin treatment varied between 8 and 30 mmol/L. Three clinicians (3/35 (8.5%)) reported having experienced problems with frequent hypoglycaemia during ongoing insulin treatment.

Conclusions

This study demonstrates extensive differences in clinical practice regarding neonatal hyperglycaemia both within and between neonatal units in Sweden. Randomised controlled trials are needed to provide evidence for clinical guidelines and to improve and standardise the care of these infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaInfant, Premature, DiseasesPractice Patterns, Physicians'HumansInfant, NewbornSwedenIntensive Care Units, NeonatalInfant, PrematureInsulinHealth Care Surveys

Stichwörter der Autor:innen

NICUhyperglycaemiainsulinpreterm infants

Substanzen

Insulin

Autor:innen und Institutionen

  • Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.

ORCID-Profile: Ludvig Henriksson Frithiof, Itay Nilsson Zamir

Förderung

  • Region Västerbotten
  • Umeå Universitet
  • Svenska Läkaresällskapet

Zitieren

APA

Frithiof, L. H., Domellöf, M., & Zamir, I. N. (2025). Management of Neonatal Hyperglycaemia in Sweden—A Survey Study. Acta Paediatrica. https://doi.org/10.1111/apa.17583

Vancouver

Frithiof LH, Domellöf M, Zamir IN. Management of Neonatal Hyperglycaemia in Sweden—A Survey Study. Acta Paediatrica. 2025. doi:10.1111/apa.17583

BibTeX
@article{Frithiof2025,
  author = {Frithiof, Ludvig Henriksson and Domellöf, Magnus and Zamir, Itay Nilsson},
  title = {Management of Neonatal Hyperglycaemia in Sweden—A Survey Study},
  journal = {Acta Paediatrica},
  year = {2025},
  doi = {10.1111/apa.17583}
}
Kostenlos starten →